Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) PT at $37.20
Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) have received an average rating of “Buy” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued a report on […]
Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) have received an average rating of “Buy” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued a report on […]
-logo-1200x675.png?v=20240417094222&w=240&h=240&zc=2){kind=logo}
